久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines pharmaceutical-business-review
    March 26, 2021
    US-based global biotechnology company Dyadic International has announced the expansion of its partnership with South Korea-based global research biopharmaceutical company Medytox to co-develop C1 manufactured Covid-19 vaccines.
  • Vaxine and Medytox partner on Covid-19 vaccine development pharmaceutical-technology
    May 27, 2020
    Australian biotechnology company Vaxine has collaborated with South Korean biopharma firm Medytox for the development and commercialisation of its Covid-19 vaccine candidate, COVAX-19.
  • Medytox files BLA of botulinum toxin biospectrumasia
    October 15, 2018
    If approved, the BTX product will be marketed locally by Medytox Taiwan, China, a joint venture between Medytox and Dynamic Medical Technologies, a Taiwan, Chinaese medical equipment company with a specialty in aesthetic lasers.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service